Aurobindo Pharma gets USFDA nod for drug formulation facility

New Delhi, Sep 6 (UNI) Leading drug maker Aurobindo Pharma Ltd today said it has received the approval for its sterile injectable formulation facility from the US Food and Drug Authority (FDA).

The company has received the Establishment Inspection Report (EIR) in this regard for the facility located in Chitkul, near Hyderabad.

''This is the third successive USFDA approval for Unit-6 (the other approvals being for the formulation orals manufacturing facility and the sterile--API manufacturing facility),'' company said in a statement.

UNI